4-[(1H-1,2,3-Benzotriazol-1-ylmethyl)amino]benzonitrile, 250mg

N-Acétyl-D-mannosamine, min 98%, 5 g, emballage plastique.

N-(Ethylcarbamoyl)-3-(4-((5-formyl-4-methoxy-2-phenyl-1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophene-2-sulfonamide, 98%, 5mg

7-Fluoroindoline, 95.0%, 250mg

tert-Butyl trans-4-formylcyclohexylcarbamate, 95, 10g

8-benzyl-4-(3-methylbut-2-enoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Diethylcarbamazine>98.0%(GC)1g

(4-Fluoro-3,5-dimethoxyphenyl)boronic acid, 95.0%, 5g

N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, 95+%, 50mg

6-(tert-Butoxy)-6-oxohexanoic acid, 95%, 10g

6,6-Dimethoxy-2,5,5-Trimethyl-2-Hexen, 98%, 500g

3-Methyl-5-phenyl-1H-pyrazole, 95.0%, 5g

6-Methyl-1H-pyrrolo[3,2-b]pyridin-2(3H)-one, 95+%, 1g